Complex positive selection pressures drive the evolution of HIV-1 with different co-receptor tropisms

Science China Life Sciences

Volumn 53, Issue 10, 2010, Pages 1204-1214

  Zhang, Chi Yu ^a   Ding, Na ^a   Chen, Ke Ping ^a   Yang, Rong Ge ^b  

^a JIANGSU UNIVERSITY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

adaptive evolution; epitopes; Gp120; HIV 1 co receptor tropism; positively selected site; R5 and X4

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GP41 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; ENVELOPE GENE; GENETIC SELECTION; GENETIC VARIABILITY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; MOLECULAR GENETICS; PHYSIOLOGY; STRUCTURAL GENE; VIROLOGY; VIRUS GENE;

AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; GENES, ENV; GENES, GAG; GENES, POL; GENES, VIRAL; GENETIC VARIATION; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, HIV; SELECTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77958459054     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-4066-5     Document Type: Article

References (47)

1. Berger E A, Murphy P M, Farber J M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol, 1999, 17: 657-700.
2. Regoes R R, Bonhoeffer S. The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol, 2005, 13: 269-277.
3. Moore J P, Kitchen S G, Pugach P, et al. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses, 2004, 20: 111-126.
4. Berger E A, Doms R W, Fenyo E M, et al. A new classification for HIV-1. Nature, 1998, 391: 240.
5. Bjorndal A, Deng H, Jansson M, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol, 1997, 71: 7478-7487.
6. Connor R I, Sheridan K E, Ceradini D, et al. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med, 1997, 185: 621-628.
7. Ross H A, Rodrigo A G. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol, 2002, 76: 11715-11720.
8. Choisy M, Woelk C H, Guegan J F, et al. Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol, 2004, 78: 1962-1970.
9. Nielsen R, Yang Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics, 1998, 148: 929-936.
10. Yang W, Bielawski J P, Yang Z. Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J Mol Evol, 2003, 57: 212-221.
11. Travers S A, O'Connell M J, McCormack G P, et al. Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. J Virol, 2005, 79: 1836-1841.
12. Zanotto P M, Kallas E G, de Souza R F, et al. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics, 1999, 153: 1077-1089.
13. de Oliveira T, Salemi M, Gordon M, et al. Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? Genetics, 2004, 167: 1047-1058.
14. Soares A E, Soares M A, Schrago C G. Positive selection on HIV accessory proteins and the analysis of molecular adaptation after interspecies transmission. J Mol Evol, 2008, 66: 598-604.
15. Carvajal-Rodriguez A, Posada D, Perez-Losada M, et al. Disease progression and evolution of the HIV-1 env gene in 24 infected infants. Infect Genet Evol, 2008, 8: 110-120.
16. Leal E, Janini M, Diaz R S. Selective pressures of human immunodeficiency virus type 1 (HIV-1) during pediatric infection. Infect Genet Evol, 2007, 7: 694-707.
17. Williamson S. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol, 2003, 20: 1318-1325.
18. Yamaguchi Y, Gojobori T. Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA, 1997, 94: 1264-1269.
19. Jensen M A, Li F S, van't Wout A B, et al. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol, 2003, 77: 13376-13388.
20. Sing T, Low A J, Beerenwinkel N, et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther, 2007, 12: 1097-1106.
21. Xu S, Huang X, Xu H, et al. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol, 2007, 45: 441-446.
22. Nozawa M, Suzuki Y, Nei M. Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci USA, 2009, 106: 6700-6705.
23. Tamura K, Dudley J, Nei M, et al. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4. 0. Mol Biol Evol, 2007, 24: 1596-1599.
24. Guindon S, Lethiec F, Duroux P, et al. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res, 2005, 33: W557-W559.
25. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol, 2007, 24: 1586-1591.
26. Yang Z, Nielsen R, Goldman N, et al. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics, 2000, 155: 431-449.
27. Anisimova M, Bielawski J P, Yang Z. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol, 2001, 18: 1585-92.
28. Anisimova M, Bielawski J P, Yang Z. Accuracy and power of bayes prediction of amino acid sites under positive selection. Mol Biol Evol, 2002, 19: 950-958.
29. Pond S L, Frost S D. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics, 2005, 21: 2531-2533.
30. Hwang S S, Boyle T J, Lyerly H K, et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 1991, 253: 71-74.
31. Javaherian K, Langlois A J, LaRosa G J, et al. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science, 1990, 250: 1590-1593.
32. Wain L V, Bailes E, Bibollet-Ruche F, et al. Adaptation of HIV-1 to its human host. Mol Biol Evol, 2007, 24: 1853-1860.
33. Sarafianos S G, Das K, Tantillo C, et al. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA: DNA. EMBO J, 2001, 20: 1449-1461.
34. Parren P W, Moore J P, Burton D R, et al. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS, 1999, 13 Suppl A: S137-S162.
35. Klenerman P, Wu Y, Phillips R. HIV: current opinion in escapology. Curr Opin Microbiol, 2002, 5: 408-413.
36. Fouchier R A, Groenink M, Kootstra N A, et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol, 1992, 66: 3183-3187.
37. Xiao L, Owen S M, Goldman I, et al. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology, 1998, 240: 83-92.
38. Boyd M T, Simpson G R, Cann A J, et al. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol, 1993, 67: 3649-3652.
39. Smyth R J, Yi Y, Singh A, et al. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J Virol, 1998, 72: 4478-4484.
40. Groenink M, Fouchier R A, Broersen S, et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science, 1993, 260: 1513-1516.
41. Pastore C, Nedellec R, Ramos A, et al. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol, 2006, 80: 750-758.
42. Sullivan N, Thali M, Furman C, et al. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J Virol, 1993, 67: 3674-3679.
43. Ghaffari G, Tuttle D L, Briggs D, et al. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. J Virol, 2005, 79: 13250-13261.
44. Cho M W, Lee M K, Carney M C, et al. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol, 1998, 72: 2509-2515.
45. Bunnik E M, Pisas L, van Nuenen A C, et al. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol, 2008, 82: 7932-7941.
46. Chambers P, Pringle C R, Easton A J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol, 1990, 71: 3075-3080.
47. Zhang C Y, Wei J F, He S H. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. BMC Microbiol, 2006, 6: 88.